I was surprised and pleased to see this article in my local paper this
morning. It's about trials using minocycline to treat early multiple sclerosis:
http://www.canada.com/vancouversun/news/story.html?
id=0ff4e564-96bd-4915-8438-e6cf7734a2f2&k=77334
Well, we know why the difference in the second trial with Copaxone was not as effective. They used it with a suppressant.
"Nowadays, researchers are no longer at all sure how Copaxone works. The is some evidence that it converts the body's immune response from a Th1 type to a Th2 one, promotes suppressor T cells or acts as an altered peptide ligand."
But it's a step in the right direction.
Pip
I think it's a pretty big development. The study is large with a lot of funding.